Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Lindberg

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
The European Respiratory Journal|May 30, 2015
Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and DAntonio Anzueto, Christine R Jenkins, Barry J Make, et al.
Contact Dermatitis|June 24, 2004
Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickelIngegärd Anveden, Magnus Lindberg, Klaus E Andersen, et al.
Contact Dermatitis|October 27, 2021
Contact allergy to haptens in the Swedish baseline series: Results from the Swedish Patch Test Register (2010 to 2017)Daniel Andernord, Magnus Bruze, Ing-Liss Bryngelsson, et al.
Journal of Affective Disorders|March 13, 2025
Help-seeking preferences and barriers for mental health problems among university students in Portugal, Germany, and SwedenLara Guedes Pinho, Maria Engström, Maria Revés Silva, et al.
European Journal of Heart Failure|May 27, 2010
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)Sally C Inglis, John J V McMurray, Michael Böhm, et al.
European Journal of Heart Failure|January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideHans Wedel, John J V McMurray, Magnus Lindberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.
Acta Dermato-Venereologica|May 16, 2002
A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patientsMarie Lodén, Anna-Carin Andersson, Chris Anderson, et al.
Journal of the American College of Cardiology|October 2, 2010
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure)John J V McMurray, Peter Dunselman, Hans Wedel, et al.
Circulation|November 18, 2009
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisJohn J V McMurray, John Kjekshus, Lars Gullestad, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
The European Respiratory Journal|May 30, 2015
Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and DAntonio Anzueto, Christine R Jenkins, Barry J Make, et al.
Contact Dermatitis|June 24, 2004
Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickelIngegärd Anveden, Magnus Lindberg, Klaus E Andersen, et al.
Contact Dermatitis|October 27, 2021
Contact allergy to haptens in the Swedish baseline series: Results from the Swedish Patch Test Register (2010 to 2017)Daniel Andernord, Magnus Bruze, Ing-Liss Bryngelsson, et al.
Journal of Affective Disorders|March 13, 2025
Help-seeking preferences and barriers for mental health problems among university students in Portugal, Germany, and SwedenLara Guedes Pinho, Maria Engström, Maria Revés Silva, et al.
European Journal of Heart Failure|May 27, 2010
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)Sally C Inglis, John J V McMurray, Michael Böhm, et al.
European Journal of Heart Failure|January 27, 2009
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideHans Wedel, John J V McMurray, Magnus Lindberg, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.
Acta Dermato-Venereologica|May 16, 2002
A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patientsMarie Lodén, Anna-Carin Andersson, Chris Anderson, et al.
Journal of the American College of Cardiology|October 2, 2010
Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure)John J V McMurray, Peter Dunselman, Hans Wedel, et al.
Circulation|November 18, 2009
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisJohn J V McMurray, John Kjekshus, Lars Gullestad, et al.
Pageof 13